paraquat has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kannan, K; Lakuleswaran, M; Li, ZM | 1 |
| Cui, Y; Mei, L; Tao, Y; Wang, Z; Xin, H | 1 |
2 other study(ies) available for paraquat and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
LC-MS/MS methods for the determination of 30 quaternary ammonium compounds including benzalkonium and paraquat in human serum and urine.
Topics: Benzalkonium Compounds; Chromatography, Liquid; COVID-19; Diquat; Humans; Pandemics; Paraquat; Quaternary Ammonium Compounds; Tandem Mass Spectrometry | 2023 |
Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway.
Topics: Acute Lung Injury; Animals; Arenaria Plant; COVID-19; COVID-19 Drug Treatment; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Paraquat; Phytotherapy; Pulmonary Edema; Pulmonary Fibrosis; SARS-CoV-2; Signal Transduction; Smad2 Protein; Smad3 Protein; Survival Rate; Transforming Growth Factor beta1 | 2021 |